18:2 PG
Manufacturer: Sigma Aldrich
CAS Number: 322729-38-4
Synonym(S): 1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1′racglycerol) (sodium salt); PG(18:2(9Z,12Z)/18:2(9Z,12Z))
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 840485C-25-MG | In Stock | ₹ 45,887.40 |
840485C - 25 MG
In Stock
Quantity
1
Base Price: ₹ 45,887.40
GST (18%): ₹ 8,259.732
Total Price: ₹ 54,147.132
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 2.5 mL (840485C-25mg)
manufacturer/tradename
Avanti Polar Lipids 840485C
concentration
10 mg/mL (840485C-25mg)
lipid type
cardiolipinsphospholipids
shipped in
dry ice
storage temp.
−20°C
InChI
1S/C42H75O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h11-14,17-20,39-40,43-44H,3-10,15-16,21-38H2,1-2H3,(H,47,48);/q;+1/p-1/b13-11-,14-12-,19-17-,20-18-;/t39?,40-;/m1./s1
InChI key
ZIOOVFPFWVCCEB-WDFQPZSRSA-M
Related Products
Description
- General description: 18:2 PG or 1,2-dilinoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) is a sodium salt of glycerophospholipid, with substitution of two chains of linolenic acid at the sn-1 and sn-2 positions and phospho-(1′-rac-glycerol) at the sn-3 position of the glycerol backbone. It is a poly-unsaturated lipid molecule.[1]
- Application: 18:2 PG or 1,2-dilinoleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) might be used in saposin-derived lipid nanoparticles (SapNPs) formation to study the lipid specificity of saposins.[1]
- Packaging: 5 mL Clear Glass Sealed Ampule (840485C-25mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (840485C-25mg)
manufacturer/tradename: Avanti Polar Lipids 840485C
concentration: 10 mg/mL (840485C-25mg)
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C42H75O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h11-14,17-20,39-40,43-44H,3-10,15-16,21-38H2,1-2H3,(H,47,48);/q;+1/p-1/b13-11-,14-12-,19-17-,20-18-;/t39?,40-;/m1./s1
InChI key: ZIOOVFPFWVCCEB-WDFQPZSRSA-M
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (840492C-25mg)pkg of 1 × 4 mL (840492C-100mg)
manufacturer/tradename: Avanti Polar Lipids 840492C
concentration: 10 mg/mL (840492C-25mg)25 mg/mL (840492C-100mg)
lipid type: __
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C50H75O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-49(53)57-45-48(46-59-61(55,56)58-44-47(52)43-51)60-50(54)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h5-8,11-14,17-20,23-26,29-32,35-38,47-48,51-52H,3-4,9-10,15-16,21-22,27-28,33-34,39-46H2,1-2H3,(H,55,56);/q;+1/p-1/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-,25-23-,26-24-,31-29-,32-30-,37-35-,38-36-;/t47?,48-;/m1./s1
InChI key: LUJLIUULIHKZSH-LJVBEQEHSA-M
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (840497C-25mg)
manufacturer/tradename: Avanti Polar Lipids 840497C
concentration: 10 mg/mL (840497C-25mg)
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C40H75O10P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h11,13,17-18,37-38,41-42H,3-10,12,14-16,19-36H2,1-2H3,(H,45,46);/q;+1/p-1/b13-11-,18-17-;/t37?,38-;/m1./s1
InChI key: JBOGSUDWCXWRFD-YBBFZHODSA-M
